Brokerages Set Align Technology, Inc. (NASDAQ:ALGN) Target Price at $206.07

Shares of Align Technology, Inc. (NASDAQ:ALGN) have received an average recommendation of “Moderate Buy” from the fifteen research firms that are currently covering the stock, MarketBeat reports. Six analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $206.3571.

ALGN has been the topic of several research reports. Evercore upped their price objective on Align Technology from $200.00 to $220.00 in a report on Thursday, April 30th. UBS Group reissued a “neutral” rating and issued a $189.00 target price on shares of Align Technology in a research note on Thursday, July 23rd. Zacks Research downgraded Align Technology from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 16th. Weiss Ratings raised Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Finally, Citigroup assumed coverage on Align Technology in a report on Wednesday, April 15th. They issued a “buy” rating and a $240.00 price target on the stock.

More Align Technology News

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q2 results exceeded expectations: Align reported adjusted earnings of $2.64 per share, ahead of analysts’ approximately $2.62 consensus estimate and up from $2.49 a year earlier. Revenue increased 4.3% year over year to $1.056 billion, also topping estimates near $1.05 billion. Align Technology Announces Second Quarter 2026 Financial Results
• Positive Sentiment: Board and strategic overhaul: Align will add three independent directors and conduct an operating review after discussions with Elliott. The changes could improve corporate governance, sharpen execution and increase the prospect of shareholder-friendly actions. Align Technology to overhaul board following engagement with Elliott
• Neutral Sentiment: Third-quarter outlook was broadly in line: Align issued revenue guidance of approximately $1.0 billion, consistent with consensus expectations. The available guidance did not include a specific EPS figure, limiting visibility into near-term profitability.
• Neutral Sentiment: Analyst coverage remains constructive, with the reported average price target of $206.07 above the stock’s recent trading level, though price targets are subject to revision after the earnings release. Align Technology Receives Average Price Target from Analysts
• Negative Sentiment: Growth remains moderate: Although revenue and earnings improved, the 4.3% annual revenue increase and roughly $1.0 billion third-quarter outlook may not signal a sharp acceleration. Investors will likely focus on Invisalign volume, scanner demand and whether the operational review produces stronger growth.

Align Technology Trading Up 2.6%

Shares of NASDAQ ALGN opened at $180.08 on Thursday. Align Technology has a 1-year low of $122.00 and a 1-year high of $207.08. The company has a market cap of $12.90 billion, a PE ratio of 30.21, a P/E/G ratio of 1.80 and a beta of 1.67. The company has a 50-day moving average of $174.24 and a two-hundred day moving average of $175.25.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings results on Wednesday, July 29th. The medical equipment provider reported $2.64 EPS for the quarter, beating the consensus estimate of $2.62 by $0.02. The business had revenue of $1.06 billion for the quarter, compared to analysts’ expectations of $1.05 billion. Align Technology had a net margin of 10.50% and a return on equity of 15.82%. Align Technology’s revenue was up 4.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.49 earnings per share. As a group, equities research analysts forecast that Align Technology will post 9.48 earnings per share for the current year.

Align Technology announced that its Board of Directors has authorized a stock buyback program on Wednesday, April 29th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the medical equipment provider to repurchase up to 1.6% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s management believes its stock is undervalued.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Sequoia Financial Advisors LLC grew its stake in shares of Align Technology by 320.1% during the fourth quarter. Sequoia Financial Advisors LLC now owns 7,986 shares of the medical equipment provider’s stock worth $1,247,000 after purchasing an additional 6,085 shares during the period. Northwestern Mutual Wealth Management Co. lifted its stake in Align Technology by 35,513.8% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 545,604 shares of the medical equipment provider’s stock valued at $85,196,000 after buying an additional 544,072 shares during the period. Polianta Ltd acquired a new position in Align Technology in the fourth quarter valued at about $1,623,000. Wealth Enhancement Advisory Services LLC boosted its holdings in Align Technology by 63.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 25,343 shares of the medical equipment provider’s stock worth $4,282,000 after buying an additional 9,792 shares during the last quarter. Finally, Hunter Perkins Capital Management LLC boosted its holdings in Align Technology by 383.1% during the fourth quarter. Hunter Perkins Capital Management LLC now owns 43,842 shares of the medical equipment provider’s stock worth $6,846,000 after buying an additional 34,767 shares during the last quarter. 88.43% of the stock is currently owned by institutional investors and hedge funds.

About Align Technology

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.